CVS Health (CVS) Tops Q4 EPS by 14c; Trims Outlook
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $84.95 -1.06%
EPS Growth %: +2.5%
Financial Fact:
Operating expenses: 4.68B
Today's EPS Names:
LGCY, UXIN, SCHL, More
EPS Growth %: +2.5%
Financial Fact:
Operating expenses: 4.68B
Today's EPS Names:
LGCY, UXIN, SCHL, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q4 EPS of $2.12, $0.14 better than the analyst estimate of $1.98. Revenue for the quarter came in at $93.81 billion versus the consensus estimate of $90.25 billion.
GUIDANCE:
CVS Health sees FY2024 EPS of at least $8.30, versus its prior view of at least $8.50 and the consensus of $8.50.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
- Paychex (PAYX) Tops Q1 EPS by 2c
- UBS Reiterates Buy Rating on CVS Health (CVS) Despite Recent Stock Weakness
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
